FINANCIALS

SPRY Ars Pharmaceuticals Inc 1671858

Income Statement
Revenue	spry-20240930	2,068,000
Net Income	spry-20240930	-19,128,000
Profit Margin		-924.95%

Balance Sheet
Current Assets	208,789,000
Assets	217,601,000
Current Liabilities	16,623,000
Liabilities	16,623,000
Equity	200,978,000
Shares Out	96,942,000

Cash Flow Statement
Operating Cash Flow	-28,456,000
Investing Cash Flow	-4,341,000

Market Analysis
Market Cap	1,240,852,114
Price	14.66
BVPS	2.07
PB	5.66
EPS	-0.47
PS	150.01
FCF	-32,797,000

Dividends

Earnings

Find a discrepancy? The most accurate way to find company fundamental data is to view SPRY documents filed with the SEC.

SPRY Filings Clear

View A List of Tickers